Pacer BioThreat Strategy ETF
VIRS
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $2.35M invested in Pacer BioThreat Strategy ETF in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
27% less capital invested
Capital invested by funds: $3.21M → $2.35M (-$851K)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$24.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$441K |
| 2 |
LF
Lee Financial
Dallas,
Texas
|
-$51K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$35K |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Osaic Holdings
Scottsdale,
Arizona
| $1.88M | +$24.2K | +777 | +1% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $253K | -$441K | -14,173 | -63% |
|
|
3
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $206K | -$35K | -1,124 | -14% |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | +$10.4K | +335 | +262% |
|
|
LF
5
Lee Financial
Dallas,
Texas
| – | -$51K | -1,458 | Closed |
|
|
AA
6
Ancora Advisors
Cleveland,
Ohio
| – | -$11K | -203 | Closed |
|
VIRS Hedge Fund Activity: Q1 2022 in Review
4 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q1 2022, worth a combined $2.35M — down 27% from $3.21M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VIRS and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Osaic Holdings, adding an estimated $24.2K. The largest seller was Royal Bank of Canada, cutting an estimated $441K.
- 4 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q1 2022, down from 6 in Q4 2021.
- Funds reported $2.35M of Pacer BioThreat Strategy ETF stock for Q1 2022, down 27% quarter-over-quarter.
- 0 funds opened new Pacer BioThreat Strategy ETF positions in Q1 2022 and 2 closed out, a net change of -2 holders.
- The largest Pacer BioThreat Strategy ETF buyer in Q1 2022 was Osaic Holdings, an estimated $24.2K added.
- The largest Pacer BioThreat Strategy ETF seller in Q1 2022 was Royal Bank of Canada, an estimated $441K sold.
Based on aggregated 13F filings for Q1 2022.